tirzepatide osa fda (Zepbound) – A New Treatment for Obstructive Sleep Apnea and Obesity — BetterNight In a prespecified secondary analysis

Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the weight-loss drug Mounjaro.

They also chat Real Talk on Fat Loss, Medication, and Long-Term Results with Lyle McDonald | HSM 686 Read More

this January

Semaglutide injections require thoughtful dietary adjustments to minimize GI side effects and maximize efficacy

Outlook for 2030 By 2030, obesity pharmacotherapy will likely be divided into three dominant segments: oral therapies (Orforglipron), monthly injectables (Berobenatide and MariTide), and high-efficacy multi-agonists (Retatrutide, Amycretin, and CagriSema)

It is a GLP-1 (glucagon-like peptide-1) receptor agonist used for